Table 1 Patient and tumor characteristics
From: Contemporary multidisciplinary treatment of pregnancy-associated breast cancer
Demographic (N = 74) | Number | Percent |
|---|---|---|
Age at diagnosis (years) | ||
Less than 30 | 11 | 14.9 |
30-34 | 26 | 35.1 |
35-39 | 29 | 39.2 |
≥40 | 8 | 10.8 |
Median age at diagnosis:34 (range 25–40) | ||
Gestational age at diagnosis (weeks) | ||
0-12 (1st trimester) | 25 | 33.8 |
13-27 (2nd trimester) | 30 | 40.5 |
28-40 (3rd trimester) | 19 | 25.7 |
Race | ||
White | 63 | 85.1 |
Black | 4 | 5.4 |
Hispanic | 3 | 4.1 |
Asian | 4 | 5.4 |
Year of diagnosis | ||
1996-1999 | 9 | 12.2 |
2000-2004 | 19 | 25.7 |
2005-2009 | 31 | 41.9 |
2010-2012 | 15 | 20.3 |
Outcome of pregnancy | ||
Delivery of liveborn infant(s) | 68 | 91.9 |
Miscarried in 1st trimester | 1 | 1.4 |
Terminated in 1st trimester | 5 | 6.8 |
Disease stage | ||
0 | 1 | 1.4 |
I | 19 | 25.7 |
II | 42 | 56.8 |
III | 10 | 13.5 |
IV | 2 | 2.7 |
Tumor subtype | ||
ER/PR Positive | 46 | 62.2 |
HER2 Positive | 25 | 33.8 |
Triple Negative | 14 | 18.9 |
BRCA status | ||
Genetic testing performed | 50 | 67.6 |
BRCA 1 or 2 positive (N = 50) | 6 | 12.0 |
BRCA 1 and 2 negative (N = 50) | 44 | 88.0 |
Genetic testing not performed | 24 | 32.4 |